(1)
Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology As a Parameter in Osteoporotic Rat Model. MKB 2024, 56 (3), 197-202. https://doi.org/10.15395/mkb.v56.3016.